To assess the clinical and electrophysiological features of n-hexane neuropathy caused by addictive inhalation, 4 patients were studied in the progressive phase. The neurological manifestations were characterized by subacute predominantly motor polyneuropathy and disease progression despite discontinuance of the chemicals, which were similar to those reported in industrial exposure, although with a severer degree associated with anorexia and body weight loss. Electrophysiological studies showed that all showed multifocal conduction block and profound conduction slowing, as well as features of axonal degeneration. Sural nerve biopsy showed axonal loss, axonal swelling, and thin myelin probably due to retraction by axonal swelling. n-Hexane abuse causes severe subacute polyneuropathy. The mixed axonal and demyelinating electrophysiological features were consistent with peculiar pathological findings. Conduction block, probably due to paranodal myelin retraction or ongoing wallerian degeneration, is very frequent and could be responsible for the clinical deficits, especially in the early phase of illness.

Keywords:
n-Hexane neuropathy, Conduction block, Demyelination, Wallerian degeneration, Axonal swelling
1.
Herskowitz A, Ishii N, Schaumburg H: n-Hexane neuropathy. A syndrome occurring as a result of industrial exposure. N Engl J Med 1971;285:82–85.
2.
Mutti A, Ferri F, Lommi G, Lucertini S, Franchini I: n-Hexane-induced changes in nerve conduction velocities and somatosensory evoked potentials. Int Arch Occup Environ Health 1982;51:45–54.
3.
Huang C-C, Chu N-S, Cheng S-Y, Shin T-S: Biphasic recovery in n-hexane polyneuropathy. A clinical and electrophysiological study. Acta Neurol Scand 1989;80:610–615.
4.
Chang YC: Patients with n-hexane induced polyneuropathy: A clinical follow up. Br J Ind Med 1990;47:485–489.
5.
Chang CM, Yu CW, Fong KY, Leung SY, Tsin TW, Yu YL, Cheung TF, Chan SY: n-Hexane neuropathy in offset printers. J Neurol Neurosurg Psychiatry 1993;56:538–542.
6.
Takeuchi Y: n-Hexane polyneuropathy in Japan: A review of n-hexane poisoning and its preventive measure. Environ Res 1993;62:76–80.
7.
Oge AE, Yazici J, Boyacian A, Eryildiz D, Ornek I, Konyaliglu R, Cengiz Z, Oksak OZ, Asar S, Baslo A: Peripheral and central conduction in n-hexane polyneuropathy. Muscle Nerve 1994;17:1416–1430.
8.
Pastore C, Marhuenda D, Marti J, Cardona A: Early diagnosis of n-hexane-caused neuropathy. Muscle Nerve 1994;17:981–986.
9.
Shirabe T, Tsuda T, Terao A, Araki S: Toxic polyneuropathy due to glue sniffing. Report of two cases with light and electron-microscopic study of the peripheral nerves and muscles. J Neurol Sci 1974;21:101–113.
10.
Kuwabara S, Nakajima M, Tsuboi Y, Hirayama K: Multifocal conduction block in n-hexane neuropathy. Muscle Nerve 1993;16:1416–1417.
11.
Towfighi J, Gonatas NK, Pleasure D, Cooper HS, McGree L: Glue sniffer’s neuropathy. Neurology 1976;26:238–243.
12.
Smith AG, Alpers AJ: Case of the month: n-Hexane neuropathy due to rubber cement sniffing. Muscle Nerve 1997;20:1445–1450.
13.
Chang AP, England JD, Garcia CA, Sumner AJ: Case of the month: Focal conduction block in n-hexane polyneuropathy. Muscle Nerve 1998;21:964–969.
14.
Nachatman J, Couri D: An electrophysiological study of 2-hexanone and 2,5-hexanedione neurotoxicity in rats. Toxicol Lett 1984;23:141–145.
15.
Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force: Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617–618.
16.
Cornblath DR, Sumner AJ, Daube J, Gilliat RW, Brown WF, Parry GJ, Albers JW, Miller RG, Petalan J: Conduction block in clinical practice. Muscle Nerve 1991;14:869–871.
17.
Schaumburg HH, Spencer PS: Degeneration in central and peripheral nervous systems produced by pure n-hexane: An experimental study. Brain 1976;99:183–192.
18.
Jones HB, Gavanagh JB: Distortions of the nodes of Ranvier from axonal distension by filamentous masses in hexacarbon intoxication. J Neurotoxicol 1983;12:439–458.
19.
Sumner AJ, Saida K, Saida T, Siberberg DH, Asbury AK: Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve. Ann Neurol 1982;11:469–477.
20.
Chaudhry V, Cornblath DR: Wallerian degeneration in human nerves: Serial electrophysiological studies. Muscle Nerve 1992;15:687–693.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.